In a narrow office that has hidden in light corridors of a shopping center in Israel, it corresponds to Nasa's mission management in Houston.
And yet there are no rows of scientists and flight managers wearing headphones, all their faces have been installed on large screen space ships. And there is no astronomy telling them they have a problem.
Instead, three large computer screens show a world-wide satellite show, a large shoe box size, from world orbiting. There is one of many independent "independent space labs" that carry out experiments for paying clients including companies, universities and pharmaceutical chemical companies.
This is a new boundary of investigation and space research. There are no huge government agencies that move slowly like Nasa's monopoly now. The commercial sector has a place for large aerospace companies, including SpaceX and Boeing, but also starts fierce using increasingly cheaper access to the heavens.
One in Israel, SpacePharma, is trying to take advantage of one space industry that comes to a prominent: experimental micrography.
At the heart of what it provides is the ability to run tests in a situation that is currently impossible to reproduce it on the planet – zero severity, or very close to a lack of sparks, the environment. And without a constant, unavoidable lack, which has always restrained every experiment, a new field of science is promising developments.
"In space, everything is different," said Yair Glick, the director of R & D in SpacePharma. Almost nothing – even chemicals, plants and human cells – behaves the same in microgeneration as they do on Earth.
Even the most simple experiment produces new results: "If we mix water with oil, we know that the water is going down and the oil. It's not so in space," said Glick.
National space agencies have been conducting microgravity research for decades, often on the effects of astronomers' muscles and bones, but also on how it affects other elements, for example flames – they do not highlight up but instead form a ball.
The results have been amazing. One experiment carried out by the Japan Aerospace Agency on the proteins associated with Duchenne muscle dystrophy, which mainly looks at young boys and mobile leavers, looked at.
Proteins, cell building blocks, crystallize differently in space as they are abolished by drawing and forming the Earth in a more organized way. Researchers were able to record their new structure and make medicine that delayed the effects of the disease. Its creators claim that it can be possible to double the lives of patients and keep walking up to 25, instead of 12.
Rich Godwin runs the United States Space Technology Holding company, which makes research done in space and applies to the global market. Proofing commercial microgravity is a huge potential market, it believes, and expects greater successes as it privatizes. "It does not change chemistry. It's changing physics," he said. "It's like to devise the microscope."
Yossi Yamin, chief executive and founder of SpacePharma, estimates that around 30 private companies sell microgravity experiments.
There are three main ways to do. The first can be done on Earth by renting an airplane and nosediving in a parabolic flight, emulating weight. But the process is extremely skeptical and just a few seconds.
Instead, most companies rent a 250-mile space on the International Space Station, which acts as a kind of real estate agent for the Earth's low orbit. They make small automatic laboratories that are sent on a rocket, often when astronauts are provided, and folded to the wall. In these, liquids can be heated, chilled, and small automatic pumps allow customers to mix chemicals.
SpacePharma also provides free satellites, which overlooks the Earth independently. He was first sent on an Indian rocket in 2017.
In the small office in Herzliya, a city that is the Israeli technology center, the nanosatellites are manually made, in a laboratory with a 3D plastic printer and a soldering board. "If you have independent mobile units, you can order it and control of your mobile phone," said Yamin, who worked for the Israeli army satellite fleet for 25 years.
Every satellite costs around £ 2.4m but it has enough space for 12 clients, whose experiments can run at the same time, dramatically reducing the cost. The commercial space research business is worth about half a billion, it's estimated. But it's betting on market prosperity.
Pharmaceutical companies look at creating more expensive drugs in space than those made on Earth. Once these more perfect proteins are formed, they can be used as "seeds" to duplicate back on Earth. "These are the orbit-made accomplishments," said Yamin.
The next step in the field of microgravity, the interior of the industry that believes will be "space factories" where only space-made materials are produced.
Twyman Clements, chief executive of Space Tango, the US company that started launching last year and has carried out 88 space experiments, including one commissioned by Budweiser on barley and another that looked at how cannabis responds in space. But now he's moving to make products in space and bring them back.
"This is not just research. He has a scalable application," said Clements, who rode on a farm in Kentucky and made his own rockets. "We are looking at high value products made in microgravity for the Earth," he said. They need a high price tag because it costs so much to send up and down material.
Customers are already trying to make fiber optic cables, which are more efficient when producing them in space. And another product that could be produced in an orbit is retinol implants to restore vision, which are made of light proteins, but do not form well on Earth under their own weight. Space Tango looks at how it could make them in space.
"The next steps to production," said Clements. "That has not happened quite a bit again. The retina effects could be the first."
This article is part of a series on possible solutions to some of the world's most stubborn problems. What else should we cover? E-mail us to [email protected]